Our Portfolio

Below companies have either been created by Forty51 Ventures or received their first financing from Forty51 Ventures as lead, or co-lead investor, in its first institutional financing.

Mosanna Therapeutics, Basel


Metabolic Obstructive Sleep Apnea (First-in-Class)

Neuroscience Company in Stealth Mode


Neurodegenerative Diseases Associated with Immune Dysfunction

Autoimmune Company in Stealth Mode


Chronic autoimmune Diseases Associated with Multicellular Pathology and Tertiary Lymphoid Structures